Beijing, China

Chunmei Hu


 

Average Co-Inventor Count = 14.1

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: The Innovations of Chunmei Hu

Introduction

Chunmei Hu is a prominent inventor based in Beijing, China. She has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic agents for central nervous system disorders. With a total of two patents to her name, her work focuses on innovative compounds that target critical neurological conditions.

Latest Patents

Chunmei Hu's latest patents include the following:

1. **Dihydropyrazolopyrimidinone compounds as PDE2 inhibitors** - This invention is directed to dihydropyrazolopyrimidinone compounds that are useful as therapeutic agents for treating central nervous system disorders associated with phosphodiesterase 2 (PDE2). The compounds are aimed at addressing neurological and psychiatric disorders such as schizophrenia, psychosis, Parkinson's disease, Parkinson's disease dementia (PDD), and Huntington's disease, particularly those associated with striatal hypofunction or basal ganglia dysfunction.

2. **6-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors** - Similar to her first patent, this invention focuses on 6-alkyl dihydropyrazolopyrimidinone compounds that serve as therapeutic agents for the same range of central nervous system disorders linked to PDE2.

Career Highlights

Chunmei Hu has worked with notable companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and MSD R&D Co., Ltd. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the field of medicinal chemistry.

Collaborations

Throughout her career, Chunmei Hu has collaborated with esteemed colleagues such as Dong-Ming Shen and Michael P. Dwyer. These partnerships have further enhanced her research and innovation capabilities.

Conclusion

Chunmei Hu's work exemplifies the impact of innovative research in addressing complex neurological disorders. Her patents reflect a commitment to advancing therapeutic options for patients suffering from debilitating conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…